Paper29862136
Targeted repair of heart injury by stem cells fused with platelet nanovesicles.
Tang J and 21 others. Nat Biomed Eng, 2018. Cited by 183 papers, by iCite.
Cite this record
ConductScience Library. Targeted repair of heart injury by stem cells fused with platelet nanovesicles. Papers, record 29862136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29862136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL123920 | NHLBI NIH HHS | United States | R01HL123920 | PubMed and NIH | NIH RePORTER |
| R01 HL137093 | NHLBI NIH HHS | United States | R01HL137093 | PubMed and NIH | NIH RePORTER |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25907051 | Allogenic dendritic cell and tumor cell fused vaccine for targeted imaging and enhanced immunotherapeutic efficacy of gastric cancer. | Biomaterials | 2015 | https://conductscience.org/library/papers/25907051 | PubMed |
| 2 | 24036024 | Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). | J Am Coll Cardiol | 2014 | https://conductscience.org/library/papers/24036024 | PubMed |
| 3 | 27055812 | Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. | Eur Heart J | 2016 | https://conductscience.org/library/papers/27055812 | PubMed |
| 4 | 25587096 | Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. | Circ Heart Fail | 2015 | https://conductscience.org/library/papers/25587096 | PubMed |
| 5 | 21362705 | Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. | Eur Heart J | 2011 | https://conductscience.org/library/papers/21362705 | PubMed |
| 6 | 8001186 | Polymer-induced membrane fusion: potential mechanism and relation to cell fusion events. | Chem Phys Lipids | 1994 | https://conductscience.org/library/papers/8001186 | PubMed |
| 7 | 25520374 | Heart disease and stroke statistics--2015 update: a report from the American Heart Association. | Circulation | 2015 | https://conductscience.org/library/papers/25520374 | PubMed |
| 8 | 20882531 | Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. | Stem Cells | 2010 | https://conductscience.org/library/papers/20882531 | PubMed |
| 9 | 25725552 | Molecular interference of fibrin's divalent polymerization mechanism enables modulation of multiscale material properties. | Biomaterials | 2015 | https://conductscience.org/library/papers/25725552 | PubMed |
| 10 | 25205020 | Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. | Nat Commun | 2014 | https://conductscience.org/library/papers/25205020 | PubMed |
| 11 | 12712444 | Vaccination of fusion cells of rat dendritic and carcinoma cells prevents tumor growth in vivo. | Int J Cancer | 2003 | https://conductscience.org/library/papers/12712444 | PubMed |
| 12 | 24511463 | Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. | JACC Heart Fail | 2014 | https://conductscience.org/library/papers/24511463 | PubMed |
| 13 | 22336189 | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. | Lancet | 2012 | https://conductscience.org/library/papers/22336189 | PubMed |
| 14 | 27350343 | Angiopellosis as an Alternative Mechanism of Cell Extravasation. | Stem Cells | 2017 | https://conductscience.org/library/papers/27350343 | PubMed |
| 15 | 28045024 | Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. | Nat Commun | 2017 | https://conductscience.org/library/papers/28045024 | PubMed |
| 16 | 28436481 | Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity. | Sci Rep | 2017 | https://conductscience.org/library/papers/28436481 | PubMed |
| 17 | 23736926 | Infusible platelet membrane as a platelet substitute for transfusion: an overview. | Blood Transfus | 2013 | https://conductscience.org/library/papers/23736926 | PubMed |
| 18 | 22405128 | Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. | Cell Transplant | 2012 | https://conductscience.org/library/papers/22405128 | PubMed |
| 19 | 25043570 | Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. | Biomaterials | 2014 | https://conductscience.org/library/papers/25043570 | PubMed |
| 20 | 16199480 | Activated platelets contribute importantly to myocardial reperfusion injury. | Am J Physiol Heart Circ Physiol | 2006 | https://conductscience.org/library/papers/16199480 | PubMed |
Cited by113
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42932101 | Conductive MXene-Based Cardiac Patches: Topographical Approaches to Enhance Cardiomyocyte Function and Address Translational Engineering Challenges-A Review. | Ann Biomed Eng | 2026 | https://conductscience.org/library/papers/42932101 | PubMed |
| 42572731 | Application Prospects of Nanotechnology in the Diagnosis and Treatment of Cardiovascular Diseases. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42572731 | PubMed |
| 42479341 | Platelet membrane-fusing MSC-derived apoptotic extracellular vesicles enhanced cardiac repair after ischemia/reperfusion injury. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42479341 | PubMed |
| 42395877 | Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42395877 | PubMed |
| 42368581 | Engineered cell-biomimetic nanosystems for anti-inflammatory therapy: Targeting, neutralization and immunomodulation. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368581 | PubMed |
| 42166700 | Intrapericardially injected hydrogel loaded with stromal cell secretome microparticles improves post-infarction myocardial repair in pigs. | Eur Heart J | 2026 | https://conductscience.org/library/papers/42166700 | PubMed |
| 42090513 | Electroactive microneedle augmented stem cell therapy in myocardial infarction. | Sci Adv | 2026 | https://conductscience.org/library/papers/42090513 | PubMed |
| 42072700 | Synthetic-Polymer-Based Cardiac Patches for MI-Induced Heart Failure Treatment: A Review. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072700 | PubMed |
| 41924448 | Biomimetic Nanoparticles for Bone Regeneration: Construction Strategies and Therapeutic Mechanisms. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41924448 | PubMed |
| 41628339 | Harnessing hemostasis to transform surgical scars into CAR-T immunological niches. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41628339 | PubMed |
| 41587995 | Granzyme B-mimetic nanozyme for nanovesicle targeted anticancer applications. | Nat Commun | 2026 | https://conductscience.org/library/papers/41587995 | PubMed |
| 41365863 | Platelet-bioengineered hiPSC-sEVs achieve targeted repair of fibrotic sinoatrial node in preclinical SND models. | Nat Commun | 2025 | https://conductscience.org/library/papers/41365863 | PubMed |
| 41121084 | Platelet-derived biomimetic nanoplatforms: a promising drug delivery strategy for cardiovascular disease. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41121084 | PubMed |
| 40893351 | Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40893351 | PubMed |
| 40765995 | Advanced Nanomaterial Platforms for Targeted Therapy of Myocardial Ischemia-Reperfusion Injury. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/40765995 | PubMed |
| 40688662 | Curcumin-loaded milk-derived sEVs fused with platelet membrane attenuate endothelial senescence and promote spinal cord injury recovery in diabetic mice. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40688662 | PubMed |
| 40688020 | Stromal-platelet membrane-inspired nanoparticles (SPIN) for targeted heart repair. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40688020 | PubMed |
| 40673130 | Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40673130 | PubMed |
| 40589723 | Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40589723 | PubMed |
| 40576736 | Stem Cell Therapy in Ischemic Heart Failure. | Am J Cardiovasc Drugs | 2025 | https://conductscience.org/library/papers/40576736 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29862136
GET https://conductscience.org/api/papers/v1/29862136/authors?page=2